Janus Global Life Sciences Fund
The Fund’s investment objective is to seek long-term growth of capital by investing primarily in equity securities of companies located anywhere in the world and selected for their growth potential.
Overall Morningstar Rating™
(as of 02/28/2017) , Class A Shares, among 243 EAA Fund Sector Equity Healthcare Funds.
© 2016 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Ratings shown may differ between Asia, the Americas and Europe, as well as between the US$ and Euro/Pound Sterling share classes (where applicable) of the Janus Capital Funds Plc.